Harrow, Inc.
US ˙ NasdaqGM ˙ US4158581094

SecurityHROW / Harrow, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership56,380 shares
Latest Disclosed Value $ 2,762,620
Barclays Plc reports 3.69% increase in ownership of HROW / Harrow, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 56,380 shares of Harrow, Inc. (US:HROW) valued at $2,762,620 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 54,371 shares of Harrow, Inc.. This represents a change in shares of 3.69% during the quarter. The current value of the position is $1,878,582 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F HARROW COM 415858109 56,380 2,009 3.69 2,763 5.46 0.0007
2026-03-31 2025-09-30 13F/A-3 HARROW COM 415858109 54,371 -16,263 -23.02 2,620 21.42 0.0006
2026-03-19 2025-09-30 13F/A-2 HARROW COM 415858109 52,593 -18,041 2,365 0.0006
2025-11-12 2025-09-30 13F HARROW COM 415858109 54,371 -16,263 2,620 0.0006
2026-02-27 2025-06-30 13F/A-2 HARROW COM 415858109 70,634 24,878 54.37 2,157 77.24 0.0005
2025-08-14 2025-06-30 13F/A-1 HARROW COM 415858109 70,634 24,878 2 0.0005
2025-08-13 2025-06-30 13F HARROW COM 415858109 70,634 24,878 2 0.0002
2026-03-17 2025-03-31 13F/A-1 HARROW COM 415858109 45,756 -14,794 -24.43 1,217 -40.08 0.0003
2025-05-15 2025-03-31 13F HARROW COM 415858109 45,756 -14,794 1 0.0003
2026-03-19 2024-12-31 13F/A-1 HARROW COM 415858109 60,550 7,957 15.13 2,031 -14.09 0.0006
2025-02-13 2024-12-31 13F HARROW COM 415858109 60,550 7,957 2 0.0006
2026-03-31 2024-09-30 13F/A-2 HARROW COM 415858109 52,593 39,506 301.87 2,365 765.93 0.0006
2024-11-19 2024-09-30 13F/A-1 HARROW COM 415858109 52,593 39,506 2 0.0006
2024-11-15 2024-09-30 13F HARROW COM 415858109 52,593 39,506 2 0.0002
2026-03-23 2024-06-30 13F/A-1 HARROW COM 415858109 13,087 -31,311 -70.52 273 -53.49 0.0001
2024-08-14 2024-06-30 13F HARROW COM 415858109 13,087 -31,311 0 0.0001
2026-03-24 2024-03-31 13F/A-1 HARROW COM 415858109 44,398 -11,417 -20.46 587 -6.08 0.0002
2024-05-15 2024-03-31 13F HARROW COM 415858109 44,398 -11,417 1 0.0002
2026-03-25 2023-12-31 13F/A-1 HARROW COM 415858109 55,815 19,951 55.63 625 21.36 0.0002
2024-02-15 2023-12-31 13F HARROW COM 415858109 55,815 19,951 1 0.0002
2026-03-26 2023-09-30 13F/A-1 HARROW COM 415858109 35,864 22,620 170.79 515 104.37 0.0003
2023-11-07 2023-09-30 13F HARROW COM 415858109 35,864 22,620 1 0.0003
2026-03-30 2023-06-30 13F/A-2 HARROW HEALTH COM 415858109 13,244 -18,530 -58.32 252 -62.50 0.0002
2023-09-20 2023-06-30 13F/A-1 HARROW HEALTH COM 415858109 13,244 -18,530 0 0.0002
2023-08-03 2023-06-30 13F HARROW HEALTH COM 415858109 13,244 -18,530 0 0.0002
2026-03-30 2023-03-31 13F/A-1 HARROW HEALTH COM 415858109 31,774 15,201 91.72 672 175.41 0.0003
2023-05-04 2023-03-31 13F HARROW HEALTH COM 415858109 31,774 15,201 1 0.0003
2026-03-30 2022-12-31 13F/A-1 HARROW HEALTH COM 415858109 16,573 13,013 365.53 245 467.44 0.0001
2023-02-13 2022-12-31 13F HARROW HEALTH COM 415858109 16,573 13,013 0 0.0001
2022-11-03 2022-09-30 13F HARROW HEALTH COM 415858109 3,560 1,093 44.30 43 138.89 0.0000
2022-08-12 2022-06-30 13F HARROW HEALTH COM 415858109 2,467 0 0.00 18 5.88 0.0000
2022-05-16 2022-03-31 13F HARROW HEALTH COM 415858109 2,467 0 0.00 17 -19.05 0.0000
2022-02-23 2021-12-31 13F/A-1 HARROW HEALTH COM 415858109 2,467 -2,945 -54.42 21 -57.14 0.0000
2022-02-14 2021-12-31 13F HARROW HEALTH COM 415858109 2,467 -2,945 21 0.0000
2021-11-09 2021-09-30 13F HARROW HEALTH COM 415858109 5,412 2,950 119.82 49 113.04 0.0000
2021-08-13 2021-06-30 13F HARROW HEALTH COM 415858109 2,462 2,462 23 0.0000
2021-02-11 2020-12-31 13F HARROW HEALTH COM 415858109 0 -55,495 -100.00 0 -100.00
2020-11-12 2020-09-30 13F HARROW HEALTH COM 415858109 55,495 6,359 12.94 310 21.09 0.0002
2020-08-12 2020-06-30 13F HARROW HEALTH COM 415858109 49,136 48,758 12,898.94 256 25,500.00 0.0002
2020-05-13 2020-03-31 13F HARROW HEALTH COM 415858109 378 378 -99.23 1 -99.61 0.0000
2020-02-10 2019-12-31 13F HARROW HEALTH COM 415858109 0 -55,047 -100.00 0 -100.00
2019-11-15 2019-09-30 13F/A-1 HARROW HEALTH COM 415858109 55,047 55,047 0.00 309 0.00 0.0002
2019-11-14 2019-09-30 13F HARROW HEALTH COM 415858109 55,047 309
2019-05-15 2019-03-31 13F IMPRIMIS PHARMACEUTICALS COM 45323A201 0 -55,000 -100.00 0 -100.00
2019-02-14 2018-12-31 13F IMPRIMIS PHARMACEUTICALS COM 45323A201 55,000 55,000 313 0.0002
2018-08-14 2018-06-30 13F IMPRIMIS PHARMACEUTICALS COM 45323A201 0 -1 -100.00 0 -100.00 0.0000
2018-05-15 2018-03-31 13F IMPRIMIS PHARMACEUTICALS COM 45323A201 1 1 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.